Amy E. Marriott

Pembroke Place
Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Animal models in venom and antivenom research: The need to align academic discovery with manufacturing and regulatory expectations.

Animal models in venom and antivenom research: The need to align academic discovery with manufacturing and regulatory expectations.

Journal: PLoS neglected tropical diseases

Published: July 27, 2026

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.

Journal: Virulence

Published: July 15, 2026

Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite Treatment.

Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite Treatment.

Journal: Journal of medicinal chemistry

Published: April 09, 2026

Complying with ARRIVE 2.0: Reporting essentials for animal models of envenoming therapeutic efficacy testing.

Complying with ARRIVE 2.0: Reporting essentials for animal models of envenoming therapeutic efficacy testing.

Journal: Toxicon : official journal of the International Society on Toxinology

Published: August 04, 2025

Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani.

Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romani.

Journal: PLoS neglected tropical diseases

Published: February 26, 2025

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites.

Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites.

Journal: Nature

Published: December 16, 2024

Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review.

Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review.

Journal: Thrombosis and haemostasis

Published: August 30, 2024

Molecular dissection of cobra venom highlights heparinoids as an antidote for spitting cobra envenoming.

Molecular dissection of cobra venom highlights heparinoids as an antidote for spitting cobra envenoming.

Journal: Science translational medicine

Published: July 17, 2024

Plug and play virus-like particles for the generation of anti-toxin antibodies.

Plug and play virus-like particles for the generation of anti-toxin antibodies.

Journal: Toxicon: X

Published: May 08, 2024

Improving in vivo assays in snake venom and antivenom research: A community discussion.

Improving in vivo assays in snake venom and antivenom research: A community discussion.

Journal: F1000Research

Published: March 06, 2024

Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19.

Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19.

Journal: Viruses

Published: February 19, 2024

African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages.

African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages.

Journal: BMJ global health

Published: December 11, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026